Vissing, J, Jacob, S, Fujita, K P, O’Brien, F, Howard, J F, The REGAIN Study Group, Mazia, C G, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D’Hont, A, Tilkin, P, Alves de Siqueira Carvalho, A, Dias Brockhausen, I, Feder, D, Ambrosio, D, César, P, Melo, A P, Martins Ribeiro, R, Rocha, R, Rosa, B B, Veiga, T, da Silva, L A, Andersen, H, Harbo, T, Vinge, L, Krogh, S, Mogensen, A, Vissing, J, Højgaard, J, Witting, N, Autzen, A M O, Pedersen, J & Weiss, M 2020, ' ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab ', Journal of Neurology, vol. 267, pp. 1991-2001 . https://doi.org/10.1007/s00415-020-09770-y JOURNAL OF NEUROLOGY Journal of Neurology Journal of neurology, 267(7), 1991-2001. D. Steinkopff-Verlag
Annals of Clinical and Translational Neurology Annals of Clinical and Translational Neurology, Vol 7, Iss 8, Pp 1327-1339 (2020) ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY Annals of clinical and translational neurology, 7(8), 1327-1339. John Wiley and Sons Ltd
Andersen, H, Mantegazza, R, Wang, J J, O’Brien, F, Patra, K, Howard, J F & The REGAIN Study Group 2019, ' Eculizumab improves fatigue in refractory generalized myasthenia gravis ', Quality of Life Research, vol. 28, no. 8, pp. 2247-2254 . https://doi.org/10.1007/s11136-019-02148-2 Quality of Life Research QUALITY OF LIFE RESEARCH
Siddiqi, Z A, Nowak, R J, Mozaffar, T, O'Brien, F, Yountz, M, Patti, F, Mazia, C G, Wilken, M, Wilken, M, Barroso, F, Saba, J, Rugiero, M, Bettini, M, Chaves, M, Vidal, G, Garcia, A D, De Bleecker, J, Van den Abeele, G, de Koning, K, De Mey, K, Mercelis, R, Mahieu, D, Wagemaekers, L, Van Damme, P, Depreitere, A, Schotte, C, Smetcoren, C, Stevens, O, Van Daele, S, Vandenbussche, N, Vanhee, A, Verjans, S, Vynckier, J, D'Hont, A, Tilkin, P, de Siqueira Carvalho, A A, Brockhausen, I D, Feder, D, Ambrosio, D, César, P, Melo, A P, Ribeiro, R M, Rocha, R, Rosa, B B, Andersen, H, Vissing, J, Højgaard, J, Witting, N, Pedersen, J, Weiss, M & The REGAIN Study Group 2021, ' Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab : subgroup analysis of REGAIN and its extension study ', Muscle and Nerve, vol. 64, no. 6, pp. 662-669 . https://doi.org/10.1002/mus.27422 Muscle & nerve, 64(6), 662-669. John Wiley and Sons Inc.
REGAIN Study Group 2019, ' Long-term safety and efficacy of eculizumab in generalized myasthenia gravis ', Muscle & Nerve, vol. 60, no. 1, pp. 14-24 . https://doi.org/10.1002/mus.26447 MUSCLE & NERVE Muppidi, S, Utsugisawa, K, Benatar, M, Murai, H, Barohn, R J, Illa, I, Jacob, S, Vissing, J, Burns, T M, Kissel, J T, Nowak, R J, Andersen, H, Casasnovas, C, De Bleecker, J L, Vu, T H, Mantegazza, R, O'Brien, F L, Wang, J J, Fujita, K P, Howard, J F & REGAIN Study Group 2019, ' Long-term safety and efficacy of eculizumab in generalized myasthenia gravis ', Muscle & Nerve, vol. 60, no. 1, pp. 14-24 . https://doi.org/10.1002/mus.26447 Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona Muscle & nerve, 60(1), 14-24. John Wiley and Sons Inc.
Lancet neurology, 16(12), 976-986. Lancet Publishing Group LANCET NEUROLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau Universitat Pompeu Fabra